138 related articles for article (PubMed ID: 16868537)
21. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
Okarvi SM
Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
[TBL] [Abstract][Full Text] [Related]
22. Radionuclide imaging of infection: in search of the grail.
Palestro CJ
J Nucl Med; 2009 May; 50(5):671-3. PubMed ID: 19372472
[No Abstract] [Full Text] [Related]
23. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
Boerman OC; Dams ET; Oyen WJ; Corstens FH; Storm G
Inflamm Res; 2001 Feb; 50(2):55-64. PubMed ID: 11289655
[TBL] [Abstract][Full Text] [Related]
24. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.
van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; van der Meer JW; Corstens FH
Eur J Nucl Med; 1998 May; 25(5):535-46. PubMed ID: 9575251
[TBL] [Abstract][Full Text] [Related]
25. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
Sosabowsky J; Melendez-Alafort L; Mather S
Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Efficacy of Targeted Imaging Agents.
Graham MM; Weber WA
J Nucl Med; 2016 Apr; 57(4):653-9. PubMed ID: 26769867
[TBL] [Abstract][Full Text] [Related]
27. Target-specific delivery of peptide-based probes for PET imaging.
Chen K; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1005-22. PubMed ID: 20851156
[TBL] [Abstract][Full Text] [Related]
28. Folate-receptor-targeted radionuclide imaging agents.
Ke CY; Mathias CJ; Green MA
Adv Drug Deliv Rev; 2004 Apr; 56(8):1143-60. PubMed ID: 15094212
[TBL] [Abstract][Full Text] [Related]
29. The future of infection imaging.
Buscombe JR
Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):99-103. PubMed ID: 16770299
[TBL] [Abstract][Full Text] [Related]
30. Targeting the treatment of drug abuse with molecular imaging.
Schiffer WK; Liebling CN; Patel V; Dewey SL
Nucl Med Biol; 2007 Oct; 34(7):833-47. PubMed ID: 17921034
[TBL] [Abstract][Full Text] [Related]
31. Future diagnostic agents.
Gemmel F; Dumarey N; Welling M
Semin Nucl Med; 2009 Jan; 39(1):11-26. PubMed ID: 19038597
[TBL] [Abstract][Full Text] [Related]
32. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
33. Imaging T-lymphocytes in inflammatory diseases: a nuclear medicine approach.
Malviya G; Galli F; Sonni I; Signore A
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):237-57. PubMed ID: 25265246
[TBL] [Abstract][Full Text] [Related]
34. Imaging infection/inflammations. Pathophysiologic basis and radiopharmaceuticals.
Weiner RE; Thakur ML
Q J Nucl Med; 1999 Mar; 43(1):2-8. PubMed ID: 10230276
[TBL] [Abstract][Full Text] [Related]
35. Radiolabelled peptides and monoclonal antibodies for therapy decision making in inflammatory diseases.
Malviya G; Signore A; Laganà B; Dierckx RA
Curr Pharm Des; 2008; 14(24):2401-14. PubMed ID: 18781990
[TBL] [Abstract][Full Text] [Related]
36. Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions.
Hartung D; Schäfers M; Fujimoto S; Levkau B; Narula N; Kopka K; Virmani R; Reutelingsperger C; Hofstra L; Kolodgie FD; Petrov A; Narula J
Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S1-8. PubMed ID: 17497106
[TBL] [Abstract][Full Text] [Related]
37. Folate receptor-targeted drugs for cancer and inflammatory diseases.
Low PS; Antony AC
Adv Drug Deliv Rev; 2004 Apr; 56(8):1055-8. PubMed ID: 15094205
[No Abstract] [Full Text] [Related]
38. [Guidelines for technetium-99m antigranulocyte scintigraphy in inflammatory or infectious diseases].
Becker W
Nuklearmedizin; 1999; 38(6A):249-50. PubMed ID: 10510822
[No Abstract] [Full Text] [Related]
39. Peptide radiopharmaceuticals for diagnosis and therapy.
Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
[TBL] [Abstract][Full Text] [Related]
40. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
Eberle AN; Mild G
J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
